Non-Germline BRCA Mutated Ovarian Cancer
1 clinical trials · Condition
◉ Watch Non-Germline BRCA Mutated Ovarian Cancer
| Record | Firm | Date |
|---|---|---|
| Multicentre Study of Olaparib Maintenance Monotherapy in Platinum Sensitive Relapsed Non gBRCAm Ovarian Cancer Patients (NCT03402841) | AstraZeneca | 2018-01-30 |
Track Non-Germline BRCA Mutated Ovarian Cancer automatically
Every clearance here is in the API, with alerts when new ones post.